TOWARZYSTWO FUNDUSZY INWESTYCYJNYCH PZU SA
Position in RPRX — Royalty Pharma plc
CIK 2071170
WARSAW, R9
Position in RPRX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$30,838
New position
Shares Held
550
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#545
of 641 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026TOWARZYSTWO FUNDUSZY INWESTYCYJNYCH PZU SA holds $1,118,039 across 7 Biotechnology names. RPRX ranks #6 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,051 | $522,063 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
335 | $208,885 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
538 | $161,954 | |
| 4 | INCY |
Incyte Corp
|
922 | $104,517 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
320 | $59,929 | |
| 6 | RPRX |
Royalty Pharma plc
This page
|
550 | $30,838 | |
| 7 | INSM |
INSMED Inc
|
280 | $29,853 |
All Filings in RPRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,838 | 550 | Shares | Sole | 2026-08-07 | |
| No filing history on record for this holder in this stock. | ||||||